Emerging Chondrosarcoma Therapies Driving Growth in the Global Market
The chondrosarcoma market is entering a pivotal phase as the first wave of targeted therapies moves through late-stage development. According to DelveInsight’s analysis, the chondrosarcoma market was valued at approximately USD 15 million across the seven major markets (7MM) — the US, EU4 (Germany, France, Italy, Spain), the UK, and Japan — in 2025. With…
